CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Repurposing drugs to target nonalcoholic steatohepatitis: Auranofin, a gold-organic molecule complex for the treatment of a specifc complex trait

Carlos J. Pirola, Silvia Sookoian

Clin Mol Hepatol. 2022;28(4):806-809. Published online 2022 August 19 DOI: https://doi.org/10.3350/cmh.2022.0208

Repurposing drugs to target nonalcoholic steatohepatitis: Auranofin, a gold-organic molecule complex for the treatment of a specifc complex trait

Carlos J. Pirola, Silvia Sookoian

Clinical and Molecular Hepatology. 2022;28(4):806-809

Link1

Link2 Link3

Pathophysiology guided treatment of nonalcoholic steatohepatitis

Tuyet A T Nguyen, Arun J Sanyal

Journal of Gastroenterology and Hepatology. 2012;27:58-64

Link1 Link2

Auranofin: Repurposing an Old Drug for a Golden New Age

Christine Roder, Melanie J. Thomson

Drugs in R&D. 2015;15(1):13-20

Link1 Link2

Link3

Adiponectin as a target for the treatment of nonalcoholic steatohepatitis with thiazolidinediones: A systematic review

Stergios A. Polyzos, Christos S. Mantzoros

Metabolism. 2016;65(9):1297-1306

Link1 Link2

Cellular interactions of auranofin and a related gold complex with raw 264.7 macrophages

Rosanne M. Snyder, Christopher K. Mirabelli, Stanley T. Crooke

Biochemical Pharmacology. 1987;36(5):647-654

Link1 Link2

Repurposing Market Drugs to Target Epigenetic Enzymes in Human Diseases

Aishat Motolani, Matthew Martin, Steven Sun, Tao Lu

Drug Repurposing - Molecular Aspects and Therapeutic Applications. 2022;

Link1

Development of new drugs for the treatment of nonalcoholic steatohepatitis

Jie Ting Tang, Yi Min Mao

Journal of Digestive Diseases. 2019;21(1):3-11

Link1 Link2 Link3

Cyclophilin inhibition as a potential treatment for nonalcoholic steatohepatitis (NASH)

Daren R. Ure, Daniel J. Trepanier, Patrick R. Mayo, Robert T. Foster

Expert Opinion on Investigational Drugs. 2019;29(2):163-178

Link1

Innovative Molecular Target and Therapeutic Approaches in Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis (NAFLD/NASH) 2.0

Mariapia Vairetti, Giuseppe Colucci, Andrea Ferrigno

International Journal of Molecular Sciences. 2022;23(14):7894

Link1

S1900 Mitochondrial Complex III Is Decreased in Morbidly Obese Patients with Nonalcoholic Steatohepatitis

Kamran Qureshi, Michelle S. Johnson, Ronald H. Clements, Gary A. Abrams, Aimee L. Landar

Gastroenterology. 2008;134(4):A-780

Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Clin Mol Hepatol has participated in CrossRef Text and Data Mining service since March 1, 2015.